Chen Chuan, Wang Xiaojiao, Huang Shunping, Wang Lin, Han Lili, Yu Songtao
Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, P.R. China.
Department of Oncology, Southwest Hospital, Third Military Medical University, Chongqing 400038, P. R. China.
Oncotarget. 2017 May 16;8(20):32731-32740. doi: 10.18632/oncotarget.16387.
Aberrant activation of Notch signaling pathway has been correlated with high grade ovarian carcinoma and carcinogenesis. However, the predictive and prognostic values of Notch signaling pathway in ovarian cancer patients remains unclear. We utilize "The Kaplan-Meier plotter" (KM plotter) background database to access the prognostic values including overall survival (OS), progression-free survival (PFS), as well as post-progression survival (PPS) of four Notch receptor mRNA expression in ovarian cancer patients. Notch1 mRNA high expression was not correlated with OS, PFS and PPS for all ovarian cancer patients, but significantly correlated with poor PFS in TP53 wild type and favorite PFS in TP53 mutation type ovarian cancer patients. Notch2 mRNA high expression was significantly correlated with poor PFS for all ovarian cancer patients, especially in grade II patients. Notch3 mRNA high expression was significantly correlated with favorite PFS for all ovarian cancer patients. Notch4 mRNA high expression was significantly correlated with favorite OS, but not PFS and PPS for all ovarian cancer patients. The results strongly support that there are distinct prognostic values of four Notch receptor mRNA expression in ovarian cancer patients.
Notch信号通路的异常激活与高级别卵巢癌及肿瘤发生相关。然而,Notch信号通路在卵巢癌患者中的预测和预后价值仍不明确。我们利用“Kaplan-Meier绘图仪”(KM绘图仪)背景数据库来评估卵巢癌患者中四种Notch受体mRNA表达的预后价值,包括总生存期(OS)、无进展生存期(PFS)以及进展后生存期(PPS)。Notch1 mRNA高表达与所有卵巢癌患者的OS、PFS和PPS均无相关性,但与TP53野生型卵巢癌患者较差的PFS以及TP53突变型卵巢癌患者较好的PFS显著相关。Notch2 mRNA高表达与所有卵巢癌患者较差的PFS显著相关,尤其是在II级患者中。Notch3 mRNA高表达与所有卵巢癌患者较好的PFS显著相关。Notch4 mRNA高表达与所有卵巢癌患者较好的OS显著相关,但与PFS和PPS无关。结果有力地支持了四种Notch受体mRNA表达在卵巢癌患者中具有不同的预后价值。